University of Paris 4 - Paris-Sorbonne / Université paris IV Paris-Sorbonne

ANTARES Search for Point Sources of Neutrinos Using Astrophysical Catalogs: A Likelihood Analysis (2021) Albert A, Andre M, Anghinolfi M, Anton G, Ardid M, Aubert JJ, Aublin J, et al. Journal article New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia (2021) Trpkov K, Hes O, Williamson SR, Adeniran AJ, Agaimy A, Alaghehbandan R, Amin MB, et al. Journal article Lanreotide Autogel (LAN) 120 mg Every 14 Days in Progressive Pancreatic Neuroendocrine Tumors (panNETs): CLARINET FORTE Study (2021) Pavel ME, Cwikla J, Lombard-Bohas C, Borbath I, Shah T, Pape UF, Thanh XMT, et al. Conference contribution Spartalizumab in metastatic, well/poorly differentiated neuroendocrine neoplasms (2021) Yao JC, Strosberg J, Fazio N, Pavel ME, Bergsland E, Ruszniewski P, Halperin DM, et al. Journal article Corticotroph tumor progression after bilateral adrenalectomy (Nelson's syndrome): systematic review and expert consensus recommendations (2021) Reincke M, Albani A, Assie G, Bancos I, Brue T, Buchfelder M, Chabre O, et al. Journal article, Review article MAPK blockade, toxicities, pathogenesis and management (2021) Moreira A, Lebbe C, Heinzerling L Journal article, Review article Disentangling x-ray dichroism and birefringence via high-purity polarimetry (2021) Schmitt AT, Joly Y, Schulze KS, Marx-Glowna B, Uschmann I, Grabiger B, Bernhardt H, et al. Journal article Efficacy, safety and quality of life (QoL) with Lanreotide Autogel (LAN) 120 mg every 14 days in progressive pancreatic or midgut neuroendocrine tumors (NETs): CLARINET FORTE study results (2021) Pavel ME, Cwikla JB, Lombard-Bohas C, Borbath , Shah T, Pape UF, Thanh TXM, et al. Conference contribution Advanced small intestine well-differentiated neuroendocrine tumors (WD-SiNET): A survey of practice on 3rd line treatment (2021) Lamarca A, Cives M, De Mestier L, Crona J, Spada F, Oberg K, Pavel ME, Alonso-Gordoa T Conference contribution Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia (2021) Trpkov K, Williamson SR, Gill AJ, Adeniran AJ, Agaimy A, Alaghehbandan R, Amin MB, et al. Journal article